AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma
Open Access
- 20 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Signal Transduction and Targeted Therapy
- Vol. 6 (1), 1-12
- https://doi.org/10.1038/s41392-020-00387-1
Abstract
Osteosarcoma (OS) is the most common primary malignant bone tumor in children and adolescents. Although activator of HSP90 ATPase activity 1 (AHA1) is reported to be a potential oncogene, its role in osteosarcoma progression remains largely unclear. Since metabolism reprogramming is involved in tumorigenesis and cancer metastasis, the relationship between AHA1 and cancer metabolism is unknown. In this study, we found that AHA1 is significantly overexpressed in osteosarcoma and related to the prognosis of osteosarcoma patients. AHA1 promotes the growth and metastasis of osteosarcoma both in vitro and in vivo. Mechanistically, AHA1 upregulates the metabolic activity to meet cellular bioenergetic needs in osteosarcoma. Notably, we identified that isocitrate dehydrogenase 1 (IDH1) is a novel client protein of Hsp90-AHA1. Furthermore, the IDH1 protein level was positively correlated with AHA1 in osteosarcoma. And IDH1 overexpression could partially reverse the effect of AHA1 knockdown on cell growth and migration of osteosarcoma. Moreover, high IDH1 level was also associated with poor prognosis of osteosarcoma patients. This study demonstrates that AHA1 positively regulates IDH1 and metabolic activity to promote osteosarcoma growth and metastasis, which provides novel prognostic biomarkers and promising therapeutic targets for osteosarcoma patients.Keywords
This publication has 32 references indexed in Scilit:
- The contributions of cancer cell metabolism to metastasisDisease Models & Mechanisms, 2018
- Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-AsparaginaseCancer Cell, 2018
- Genetic factors conferring metastasis in osteosarcomaFuture Oncology, 2016
- Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma ProgressionClinical Cancer Research, 2016
- MicroRNA-198 inhibited tumorous behaviors of human osteosarcoma through directly targeting ROCK1Biochemical and Biophysical Research Communications, 2016
- c-Abl Mediated Tyrosine Phosphorylation of Aha1 Activates Its Co-chaperone Function in Cancer CellsCell Reports, 2015
- Hsp90 inhibitor induces autophagy and apoptosis in osteosarcoma cellsInternational Journal of Oncology, 2014
- Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycleNature Structural & Molecular Biology, 2013
- A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and LymphomasClinical Cancer Research, 2011
- Regulatory Posttranslational Modifications in Hsp90 Can Be Compensated by Cochaperone Aha1Molecular Cell, 2011